SCHEMBL6664062

SCHEMBL6664062

COc1cc2ncnc(Nc3ccc(NC=O)cc3)c2cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.72
KDR P35968 7/20 0.72
LCK P06239 5/20 0.72
RET P07949 2/20 0.70
RIPK2 O43353 2/20 0.70
FLT1 P17948 1/20 0.70
GAK O14976 1/20 0.70
STK10 O94804 1/20 0.70
FLT3 P36888 1/20 0.70
JAK3 P52333 1/20 0.70
AAK1 Q2M2I8 1/20 0.70
Q6ZSR9 Q6ZSR9 1/20 0.70
SLK Q9H2G2 1/20 0.70
IRAK4 Q9NWZ3 1/20 0.70
RPS6KA6 Q9UK32 1/20 0.70
ALK Q9UM73 1/20 0.70
ABCG2 Q9UNQ0 2/20 0.70
CLK1 P49759 1/20 0.70
SRC P12931 1/20 0.66
PIK3CD O00329 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668330 0.89 EGFR (0.70) EGFRKDRLCKRETFLT1
SCHEMBL6689322 0.85 PIK3CD (0.69) EGFRKDRLCKRETRIPK2
SCHEMBL21473661 0.85 KDR (0.70) EGFRKDRLCKRETRIPK2
SCHEMBL5472599 0.84 EGFR (1.00) EGFRKDRLCKRETRIPK2
SCHEMBL5473778 0.84 EGFR (0.80) EGFRKDRLCKRETRIPK2
SCHEMBL5467825 0.84 EGFR (1.00) EGFRKDRLCKRETRIPK2
SCHEMBL3533221 0.84 EGFR (0.80) EGFRKDRLCKRETRIPK2
SCHEMBL5477771 0.83 KDR (1.00) EGFRKDRLCKRETRIPK2
Whi-P131 SCHEMBL29295 0.83 EGFR (1.00) EGFRKDRLCKRETRIPK2
Hydrochloric Acid SCHEMBL8871198 0.83 EGFR (0.80) EGFRKDRLCKRETRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed